Statins are metabolised by the liver, mainly by isoenzyme CYP3A4.1 Active liver disease and a three-fold increase in the activity of aminotransferases above the upper limit of the norm during the course of the therapy was a contraindication for statin therapy. The gene discussed is CYP3A4; the disease is liver disorder.